TrimRx programs start with a real clinical intake where surgical history, current digestion, and medications shape a personalized plan with compounded semaglutide or tirzepatide and provider oversight throughout titration
Aronne et al., JAMA 2024 (SURMOUNT-4)
"The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI." 2025
doi:10.1073/pnas.0813409106, PMID: 19223582 Vali S, Mythri RB, Jagatha B, Padiadpu J, Ramanujan KS, Andersen JK, Gorin F, Bharath MM (2007) Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinsons disease: a dynamic model
Your plea for help will no longer fall on deaf ears
After phone support put me on hold with no answer, MEDVi eventually provided one pharmacy partner name (Link Compound Pharmacy) via email